PGLa and XPF peptides and uses therefor

Details PGLa and XPF peptides and uses therefor PGLa and XPF peptides and uses therefor

1992-02-14

1996-10-22

Chan, Christina Y.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 514 2, 514 21, 514934, A61K 3817

Patent

active

055676812

ABSTRACT:
The present invention relates to a method of producing antimicrobial effect by contacting a subject susceptible to microbial invasion or contamination, with antimicrobial amount of XPF and PGLa polypeptides.

REFERENCES:
patent: 3883499 (1975-05-01), Tachibana et al.
patent: 3928306 (1975-12-01), Uchiyama et al.
Giovannini e;t al, Biochem. J., 243:113-120, 1987.
Csordas et al, Toxicon &;103-108, 1969.
Kaiser et al, Proc. Natl. Acad. Sci. USA 80:1137-1143, 1983.
Sures et al, Proc. Natl. Acad. Sco. USA 81:380-384, 1984.
CRC Handbook of Chemotherapeutic Agents vol. I pp. 178-185. "Peptide Antibiotics".
Kempf et al, J. Biol. Chem. 257:2469-2476, 1982.
Steiner et al, Nature 292:246-248, 1981.
Hoffmann et al, Embo, J. 2:711-714, 1983.
Richter et al, Peptides 6:17-21, 1985.
Andreu et al, Biochem. 149:531-535, 1985.
Merrifield et al, Biochem. 21:5020-5031, 1982.
Gibson et al, J. Biol Chem. 261:5341-5349, 1986.
The Merck Manual of Diagnosis and Therapy, 11th ed., pp. 761-778, (1966).

Affiliated with

Also associated with

Rating

PGLa and XPF peptides and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PGLa and XPF peptides and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PGLa and XPF peptides and uses therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2358731